Showing results (2131-2140 of 3,476) with videos related to
Sort By:
Pageof 348
Proceedings of the National Academy of Sciences of the United States of America|March 31, 2022
Polygenic sex determination produces modular sex polymorphism in an African cichlid fishEmily C Moore, Patrick J Ciccotto, Erin N Peterson, et al.Physics in Medicine and Biology|March 10, 2023
Automated treatment planning framework for brachytherapy of cervical cancer using 3D dose predictionsKaroline Kallis, Lance C Moore, Katherina G Cortes, et al.Vaccines|September 28, 2024
Elimination of Human Papillomavirus 16-Positive Tumors by a Mucosal rAd5 Therapeutic Vaccination in a Pre-Clinical Murine StudyMolly R Braun, Anne C Moore, Jonathan D Lindbloom, et al.Scientific Reports|November 4, 2018
Metabolic profiling of adherence to diet, physical activity and body size recommendations for cancer preventionQianqian Gu, John J Spinelli, Trevor B J Dummer, et al.Emergency Medicine Journal : EMJ|August 3, 2026
Cross-sectional associations between neurodiversity and violence-related attendances in Welsh Emergency Departments and the role of Hospital-based Violence Intervention ProgrammesAmrita Bandyopadhyay, Megan Hamilton, Sinead Brophy, et al.Osteoarthritis and Cartilage|May 29, 2019
Osteophyte growth in early thumb carpometacarpal osteoarthritisJ J Crisco, A M Morton, D C Moore, et al.Geroscience|May 15, 2021
Using lipid profiling to better characterize metabolic differences in apolipoprotein E (APOE) genotype among community-dwelling older Black menMegan M Marron, Steven C Moore, Stacy G Wendell, et al.Breast Cancer Research and Treatment|June 3, 2019
Correction to: Breast cancer risk in relation to plasma metabolites among Hispanic and African American womenHua Zhao, Jie Shen, Steven C Moore, et al.Blood|June 15, 1996
An autosomal dominant, qualitative platelet disorder associated with multimerin deficiency, abnormalities in platelet factor V, thrombospondin, von Willebrand factor, and fibrinogen and an epinephrine aggregation defectC P Hayward, G E Rivard, W H Kane, et al.Cancer Research|June 1, 1977
4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone, a second-generation antineoplastic agent of the alpha-(N)-heterocyclic carboxaldehyde thiosemicarbazone seriesK C Agrawal, J B Schenkman, H Denk, et al.Pageof 348